Peggy Pinkston | Vice President, Investor Relations |
Clay Siegall | President & Chief Executive Officer |
Robin Taylor | Chief Commercial Officer |
Todd Simpson | Chief Financial Officer |
Roger Dansey | Chief Medical Officer |
Geoff Meacham | Bank of America |
Salveen Richter | Goldman Sachs |
Kennen MacKay | RBC Capital Markets |
Andrew Berens | SVB Leerink |
Matthew Harrison | Morgan Stanley |
Cory Kasimov | JPMorgan |
Michael Schmidt | Guggenheim Securities |
Shanshan Xu | Berenberg Capital Markets |
Chad Messer | Needham & Company |
Gena Wang | Barclays |
Stephen Willey | Stifel |
Andy Hsieh | William Blair |
Silvan Tuerkcan | Oppenheimer & Company |
Ladies and gentlemen, thank you for your patience and holding, and welcome to the Seattle Genetics Fourth Quarter and Full Year 2019 Financial Results Conference Call. Today's call is being recorded.
It is now my pleasure to turn the call over to Ms. Peggy Pinkston, Vice President, Investor Relations. Ma'am, please begin.